The first vaccine to prevent cervical cancer and genital diseases caused by human papilla virus will be available in pharmacies of tomorrow with a price of € 464.58 for the three doses required.

The vaccine, marketed by Sarnoff Pasteur MSD under the name of the Girasol, protects against four types of human papilla virus (HPV), two that cause cervical cancer and two that cause diseases such as genital warts.

Only four strains of HPV cause 70-75 percent of infections that degenerate into cervical cancer, so women have never been infected with this virus will be vaccinated and immunized against most genital infections caused by HPV.

Full vaccination consists of three separate doses (intramuscular injection) must be given within six months and one year (the second dose two months after the first and third and last, from the sixth month).

HPV, the virus is very common and easily transmitted, especially through sexual transmission, is the cause of Europe’s 75 per cent of cervical cancers, 70 percent of vulgar and vaginal tumors and 90 percent of genital warts.

70 percent of sexually active people are exposed to the virus at some point in their lives, the importance of vaccination of girls before they have a relationship. Continue Reading